Loading [MathJax]/extensions/tex2jax.js

Investigating Ultrafiltration Membranes and Operation Modes for Improved Lentiviral Vector Processing

Research output: Contribution to journalArticleResearchpeer review

Authors

  • Jennifer J. Labisch
  • Maria Evangelopoulou
  • Tobias Schleuß
  • Andreas Pickl

Research Organisations

External Research Organisations

  • Sartorius AG

Details

Original languageEnglish
Article numbere202400057
Number of pages12
JournalEngineering in life sciences
Volume25
Issue number1
Publication statusPublished - 9 Jan 2025

Abstract

The demand for lentiviral vectors (LVs) as tools for ex vivo gene therapies is ever-increasing. Despite their promising applications, challenges in LV production remain largely due to the fragile envelope, which challenges the maintenance of vector stability. Thus, downstream processing optimization to enhance efficiency, yield, and product quality is necessary. This study investigated the influence of membrane types and filtration devices during ultrafiltration (UF). Nine different membrane materials consisting of polyethersulfone (PES), regenerated cellulose, or Hydrosart, with distinct molecular weight cutoffs, were evaluated in stirred cells, centrifugal ultrafilters, and crossflow cassettes. The evaluation was based on the ability to retain infectious LV particles and remove impurities. The analysis revealed that a reinforced 100 kDa PES and a 300 kDa Hydrosart membrane had the best overall ability to concentrate infectious LVs and remove DNA, especially when operated in a stirred cell. Challenges were seen in the nonoptimized crossflow cassette process, where infectious LV recovery was generally lower compared to other devices. We demonstrated that membrane material and filtration device have a direct impact on the efficiency of LV UF.

Keywords

    centrifugal ultrafilters, crossflow cassettes, downstream processing, lentiviral vectors, stirred cells, tangential flow filtration, ultrafiltration

ASJC Scopus subject areas

Cite this

Investigating Ultrafiltration Membranes and Operation Modes for Improved Lentiviral Vector Processing. / Labisch, Jennifer J.; Evangelopoulou, Maria; Schleuß, Tobias et al.
In: Engineering in life sciences, Vol. 25, No. 1, e202400057, 09.01.2025.

Research output: Contribution to journalArticleResearchpeer review

Labisch JJ, Evangelopoulou M, Schleuß T, Pickl A. Investigating Ultrafiltration Membranes and Operation Modes for Improved Lentiviral Vector Processing. Engineering in life sciences. 2025 Jan 9;25(1):e202400057. doi: 10.1002/elsc.202400057
Labisch, Jennifer J. ; Evangelopoulou, Maria ; Schleuß, Tobias et al. / Investigating Ultrafiltration Membranes and Operation Modes for Improved Lentiviral Vector Processing. In: Engineering in life sciences. 2025 ; Vol. 25, No. 1.
Download
@article{2d917214612341baab7fd29b807b5cb4,
title = "Investigating Ultrafiltration Membranes and Operation Modes for Improved Lentiviral Vector Processing",
abstract = "The demand for lentiviral vectors (LVs) as tools for ex vivo gene therapies is ever-increasing. Despite their promising applications, challenges in LV production remain largely due to the fragile envelope, which challenges the maintenance of vector stability. Thus, downstream processing optimization to enhance efficiency, yield, and product quality is necessary. This study investigated the influence of membrane types and filtration devices during ultrafiltration (UF). Nine different membrane materials consisting of polyethersulfone (PES), regenerated cellulose, or Hydrosart, with distinct molecular weight cutoffs, were evaluated in stirred cells, centrifugal ultrafilters, and crossflow cassettes. The evaluation was based on the ability to retain infectious LV particles and remove impurities. The analysis revealed that a reinforced 100 kDa PES and a 300 kDa Hydrosart membrane had the best overall ability to concentrate infectious LVs and remove DNA, especially when operated in a stirred cell. Challenges were seen in the nonoptimized crossflow cassette process, where infectious LV recovery was generally lower compared to other devices. We demonstrated that membrane material and filtration device have a direct impact on the efficiency of LV UF.",
keywords = "centrifugal ultrafilters, crossflow cassettes, downstream processing, lentiviral vectors, stirred cells, tangential flow filtration, ultrafiltration",
author = "Labisch, {Jennifer J.} and Maria Evangelopoulou and Tobias Schleu{\ss} and Andreas Pickl",
note = "Publisher Copyright: {\textcopyright} 2024 The Author(s). Engineering in Life Sciences published by Wiley-VCH GmbH.",
year = "2025",
month = jan,
day = "9",
doi = "10.1002/elsc.202400057",
language = "English",
volume = "25",
journal = "Engineering in life sciences",
issn = "1618-0240",
publisher = "Wiley-VCH Verlag",
number = "1",

}

Download

TY - JOUR

T1 - Investigating Ultrafiltration Membranes and Operation Modes for Improved Lentiviral Vector Processing

AU - Labisch, Jennifer J.

AU - Evangelopoulou, Maria

AU - Schleuß, Tobias

AU - Pickl, Andreas

N1 - Publisher Copyright: © 2024 The Author(s). Engineering in Life Sciences published by Wiley-VCH GmbH.

PY - 2025/1/9

Y1 - 2025/1/9

N2 - The demand for lentiviral vectors (LVs) as tools for ex vivo gene therapies is ever-increasing. Despite their promising applications, challenges in LV production remain largely due to the fragile envelope, which challenges the maintenance of vector stability. Thus, downstream processing optimization to enhance efficiency, yield, and product quality is necessary. This study investigated the influence of membrane types and filtration devices during ultrafiltration (UF). Nine different membrane materials consisting of polyethersulfone (PES), regenerated cellulose, or Hydrosart, with distinct molecular weight cutoffs, were evaluated in stirred cells, centrifugal ultrafilters, and crossflow cassettes. The evaluation was based on the ability to retain infectious LV particles and remove impurities. The analysis revealed that a reinforced 100 kDa PES and a 300 kDa Hydrosart membrane had the best overall ability to concentrate infectious LVs and remove DNA, especially when operated in a stirred cell. Challenges were seen in the nonoptimized crossflow cassette process, where infectious LV recovery was generally lower compared to other devices. We demonstrated that membrane material and filtration device have a direct impact on the efficiency of LV UF.

AB - The demand for lentiviral vectors (LVs) as tools for ex vivo gene therapies is ever-increasing. Despite their promising applications, challenges in LV production remain largely due to the fragile envelope, which challenges the maintenance of vector stability. Thus, downstream processing optimization to enhance efficiency, yield, and product quality is necessary. This study investigated the influence of membrane types and filtration devices during ultrafiltration (UF). Nine different membrane materials consisting of polyethersulfone (PES), regenerated cellulose, or Hydrosart, with distinct molecular weight cutoffs, were evaluated in stirred cells, centrifugal ultrafilters, and crossflow cassettes. The evaluation was based on the ability to retain infectious LV particles and remove impurities. The analysis revealed that a reinforced 100 kDa PES and a 300 kDa Hydrosart membrane had the best overall ability to concentrate infectious LVs and remove DNA, especially when operated in a stirred cell. Challenges were seen in the nonoptimized crossflow cassette process, where infectious LV recovery was generally lower compared to other devices. We demonstrated that membrane material and filtration device have a direct impact on the efficiency of LV UF.

KW - centrifugal ultrafilters

KW - crossflow cassettes

KW - downstream processing

KW - lentiviral vectors

KW - stirred cells

KW - tangential flow filtration

KW - ultrafiltration

UR - http://www.scopus.com/inward/record.url?scp=85214108072&partnerID=8YFLogxK

U2 - 10.1002/elsc.202400057

DO - 10.1002/elsc.202400057

M3 - Article

AN - SCOPUS:85214108072

VL - 25

JO - Engineering in life sciences

JF - Engineering in life sciences

SN - 1618-0240

IS - 1

M1 - e202400057

ER -